436 related articles for article (PubMed ID: 17870259)
41. A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone.
Thiébaud D; Bigler JM; Renteria S; Pache T; Welti HJ; Landry M; Burckhardt P
Climacteric; 1998 Sep; 1(3):202-10. PubMed ID: 11907945
[TBL] [Abstract][Full Text] [Related]
42. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
43. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
Landgren MB; Helmond FA; Engelen S
Maturitas; 2005 Mar; 50(3):222-30. PubMed ID: 15734603
[TBL] [Abstract][Full Text] [Related]
44. Effects of tibolone and raloxifene on health-related quality of life and sexual function.
Nijland EA; Weijmar Schultz WC; Davis SR
Maturitas; 2007 Oct; 58(2):164-73. PubMed ID: 17870260
[TBL] [Abstract][Full Text] [Related]
45. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of conjugated estrogen plus medroxyprogesterone acetate versus tibolone in early postmenopausal Chinese women.
Yang TS; Tsan SH; Chen CR; Chang SP; Yuan CC
Zhonghua Yi Xue Za Zhi (Taipei); 1999 May; 62(5):308-15. PubMed ID: 10389286
[TBL] [Abstract][Full Text] [Related]
47. Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause.
Perrone G; Capri O; Galoppi P; Brunelli R; Bevilacqua E; Ceci F; Ciarla MV; Strom R
Gynecol Obstet Invest; 2009; 68(1):33-9. PubMed ID: 19349712
[TBL] [Abstract][Full Text] [Related]
48. Economic impact of tibolone compared with continuous-combined hormone replacement therapy. In the management of postmenopausal women with climacteric symptoms in the UK.
Plumb JM; Guest JF
Pharmacoeconomics; 2000 Nov; 18(5):477-86. PubMed ID: 11151401
[TBL] [Abstract][Full Text] [Related]
49. The cost-effectiveness of hormone therapy in younger and older postmenopausal women.
Salpeter SR; Buckley NS; Liu H; Salpeter EE
Am J Med; 2009 Jan; 122(1):42-52.e2. PubMed ID: 19114171
[TBL] [Abstract][Full Text] [Related]
50. Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.
Ma L; Hofling M; Masironi B; von Schoultz B; Cline JM; Sahlin L
Maturitas; 2008 Dec; 61(4):345-9. PubMed ID: 18980817
[TBL] [Abstract][Full Text] [Related]
51. Short and long term effects of tibolone in postmenopausal women.
Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
[TBL] [Abstract][Full Text] [Related]
52. Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women.
Inan I; Kelekci S; Yilmaz B
Gynecol Endocrinol; 2005 Feb; 20(2):64-7. PubMed ID: 15823823
[TBL] [Abstract][Full Text] [Related]
53. Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study.
Koh KK; Ahn JY; Jin DK; Yoon BK; Kim HS; Kim DS; Kang WC; Han SH; Choi IS; Shin EK
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1889-94. PubMed ID: 12933531
[TBL] [Abstract][Full Text] [Related]
54. Multisystem evaluations of the long-term effects of tibolone on postmenopausal monkeys.
Clarkson TB; Anthony MS; Cline JM; Lees CJ; Ederveen AG
Maturitas; 2004 Aug; 48 Suppl 1():S24-9. PubMed ID: 15337245
[TBL] [Abstract][Full Text] [Related]
55. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Vacca F; Genazzani AR
Maturitas; 2005 Feb; 50(2):91-7. PubMed ID: 15653005
[TBL] [Abstract][Full Text] [Related]
56. The effects of hormone therapy, estrogen therapy and tibolone on apoptosis and cyclin D1 expression in postmenopausal vaginal epithelium.
Sağsöz N; Yücel A; Noyan V; Bozdoğan O
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):61-6. PubMed ID: 15955616
[TBL] [Abstract][Full Text] [Related]
57. Tibolone: the way to beat many a postmenopausal ailments.
Lazovic G; Radivojevic U; Marinkovic J
Expert Opin Pharmacother; 2008 Apr; 9(6):1039-47. PubMed ID: 18377345
[TBL] [Abstract][Full Text] [Related]
58. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
[TBL] [Abstract][Full Text] [Related]
59. Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women.
Dedeoğlu EN; Erenus M; Yörük P
Fertil Steril; 2009 Feb; 91(2):425-31. PubMed ID: 18249383
[TBL] [Abstract][Full Text] [Related]
60. Effects of tibolone on the breast of postmenopausal women.
Wang PH; Cheng MH; Chao HT; Chao KC
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):121-6. PubMed ID: 17638619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
